期刊
ACS CHEMICAL NEUROSCIENCE
卷 10, 期 8, 页码 3611-3621出版社
AMER CHEMICAL SOC
DOI: 10.1021/acschemneuro.9b00216
关键词
amyloid toxicity; mitochondrial dysfunction; oxidative stress; Nrf2 signaling; inflammation; multifunctional modulator
资金
- JNCASR
- SwarnaJayanti Fellowship
- Department of Science and Technology (DST), Government of India [DST/SJF/CSA-02/2015-2016]
- Sheikh Saqr Laboratory (SSL)
- ICMS-JNCASR
- Department of Biotechnology, Govt. of India [DBT/VN-HB-NC-SB/4515]
- Council of Scientific & Industrial Research (CSIR)
Alzheimer's disease (AD) is one of the most devastating forms of dementia, without reliable treatments to cure, delay the onset, or prevent the disease progression. The proposed toxic mechanisms of AD include amyloidogenesis of amyloid beta (A beta), metal ion dyshomeostasis, redox active metal-A beta inclusion complex formation, and generation of excessive reactive oxygen and nitrogen species (ROS and RNS). The imbalance in redox homeostasis causes oxidative stress, DNA damage, mitochondrial dysfunction, and inflammation, which collectively become a major hurdle in the development of effective therapeutic agents for multifactorial AD. This necessitates a multifunctional strategy to develop effective therapeutic agents to inhibit multifaceted toxicity. In this context, we report a rational design, synthesis, and detailed study to identify a small molecule multifunctional modulator (MFM) inspired by the human origin tripeptide. The lead, MFM 4, chelates and sequesters metal ions, disrupts their redox cycles, prevents excessive ROS production and oxidative stress, ameliorates oxidative DNA damage and mitochondrial dysfunction, and modulates Nrf2 protein signaling under oxidative stress conditions by eliminating the toxic stress elements. The MFM 4 was found to inhibit metal-dependent and -independent A beta aggregation and qualified as a suitable candidate to inhibit A beta-induced neuronal toxicity. The NMR spectroscopy study revealed molecular-level interactions of 4 with A beta 42, which explain the mechanism of aggregation inhibition. Furthermore, 4 effectively inhibited inflammation as revealed by reduction in nitric oxide (NO) production in LPS-activated glial cells. These key features make 4 a potential MFM platform to develop therapeutic agents for metal (Cu, Zn and Fe)-dependent and -independent multifaceted A beta toxicity of AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据